Free Trial
LON:SPH

Sinclair Pharma (SPH) Share Price, News & Analysis

Sinclair Pharma logo

About Sinclair Pharma Stock (LON:SPH)

Advanced Chart
Remove Ads

Key Stats

Today's Range
N/A
50-Day Range
31.80
31.80
52-Week Range
N/A
Volume
373,221 shs
Average Volume
3.30 million shs
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Sinclair Pharma plc, a specialty pharmaceutical company, engages in the manufacture, commercialization, and sale of dermatological products worldwide. It provides Silhouette Soft, a resorbable poly-L-lactic acid(PLLA)/PLGA suture with bi-directional resorbable cones for skin repositioning and tightening; and Ellansé, which offers dermal fillers. The company also provides Perfectha for wrinkle correction, facial contouring, and volume restoration; and Sculptra designed to stimulate collagen growth. It serves healthcare providers and plastic surgeons. The company was formerly known as Sinclair IS Pharma plc and changed its name to Sinclair Pharma plc in December 2015. Sinclair Pharma plc was founded in 1971 and is headquartered in London, the United Kingdom.

Remove Ads
Receive SPH Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Sinclair Pharma and its competitors with MarketBeat's FREE daily newsletter.

SPH Stock News Headlines

Most gold “analysts” aren’t really gold analysts… [watch out]
People who don’t understand the gold market are about to lose a lot of money. Unfortunately, most so-called “gold analysts” have it all wrong… They tell you to invest in gold ETFs - because the popular mining ETFs will someday catch fire and close the price gap with spot gold.
Cheryl Sinclair
Dr. Robert Sinclair
Sinclair Continues To Face Challenges
See More Headlines

SPH Stock Analysis - Frequently Asked Questions

Shares of SPH stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.

Based on aggregate information from My MarketBeat watchlists, some other companies that Sinclair Pharma investors own include Vectura Group (VEC), Bristol-Myers Squibb (BMY), Energy Transfer (ET), Hikma Pharmaceuticals (HIK), Jack in the Box (JACK), Merck & Co., Inc. (MRK) and Transocean (RIG).

Industry, Sector and Symbol

Stock Exchange
LON
Sector
Medical
Industry
Drug Manufacturers - Major
Sub-Industry
N/A
Current Symbol
LON:SPH
CIK
N/A
Fax
N/A
Employees
2,021
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A
Price / Cash Flow
N/A
Price / Book
N/A

Miscellaneous

Free Float
N/A
Optionable
Not Optionable
Beta
N/A
These 7 Stocks Will Be Magnificent in 2025 Cover

Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2025. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.

Get This Free Report

This page (LON:SPH) was last updated on 4/2/2025 by MarketBeat.com Staff
From Our Partners